FDA.reportPublic FDA data

CLENZIDERM DAILY CARE FOAMING CLEANSER

Manufacturer
OMP, INC. | PURETEK CORPORATION | Ei INC.
Effective date
2011-12-15
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:30:23

Label at a glance#

ProductCLENZIDERM DAILY CARE FOAMING CLEANSER ACNE TREATMENT
Active ingredientSALICYLIC ACID
Label structure11 sections

Indications and uses

For the treatment of acne dries up acne pimples helps prevent new acne pimples

Dosage and administration

Use AM and PM. Wet face. Gently massage product all over face for 20-30 seconds avoiding eye area. Rinse thoroughly and pat dry. Wait 10-15 minutes to allow skin to dry completely.

Storage and handling

store away from heat and direct sunlight. store at controlled room temperature: 15°-25°C (59°-77°F).

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

DRUG FACTS

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic Acid 2%

Purpose

OTC - PURPOSE SECTION

Acne treatment gel

Uses

INDICATIONS & USAGE SECTION

  • For the treatment of acne
  • dries up acne pimples
  • helps prevent new acne pimples

Warnings

WARNINGS SECTION

For external use only

When using this product

OTC - WHEN USING SECTION

  • Using other topical acne medications at the same time or immediately following use of this product may increase dryness or irritation of the skin. If this occurs, only one medication should be used unless directed by a doctor.

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • irritation becomes severe.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • Use AM and PM.
  • Wet face.
  • Gently massage product all over face for 20-30 seconds avoiding eye area.
  • Rinse thoroughly and pat dry.
  • Wait 10-15 minutes to allow skin to dry completely.

Other Information

STORAGE AND HANDLING SECTION

  • store away from heat and direct sunlight.
  • store at controlled room temperature: 15°-25°C (59°-77°F).

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Butyl Avocadate, Cetyl Hydroxyethylcellulose, Cocamidopropyl Betaine, Disodium EDTA, Ethoxydiglycol, Fragrance, Menthol, Menthyl Lactate, Sodium Laureth Sulfate, Sodium Lauryl Sulfate, Ext. Violet 2 (CI 60730), Water (Aqua).

Questions?

OTC - QUESTIONS SECTION

(800) 636-7546 Mon-Fri 9:00 am – 4:00 p.m. Pacific Time

SPL UNCLASSIFIED SECTION

Dist. by OMP, Inc., Long Beach, CA 90806

PRINCIPAL DISPLAY PANEL - 118 mL Bottle Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

OBAGI®

CLENZIderm M.D.™

Daily Care
Foaming Cleanser

SALICYLIC ACID 2%
ACNE TREATMENT

1

Removes dirt
and excess
oil, leaving
skin clean
and refreshed.

4 FL.OZ. (118 mL)

Principal Display Panel - 118 mL Bottle Label
Principal Display Panel - 118 mL Bottle Label

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1235205CLENZIderm M.D. 2 % Medicated Liquid SoapPSN1
562600salicylic acid 2 % Medicated Liquid SoapPSN1
1235205salicylic acid 20 MG/ML Medicated Liquid Soap [Clenziderm]SBD1
562600salicylic acid 20 MG/ML Medicated Liquid SoapSCD1
1235205Clenziderm 20 MG/ML Medicated Liquid SoapSY1
1235205Clenziderm M.D. 2 % Daily Care CleanserSY1
562600salicylic acid 2 % Facial Cleanser TonerSY1
562600salicylic acid 2 % Facial ScrubSY1
562600salicylic acid 2 % Medicated Liquid SoapSY1

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
dea2eded-d1e7-46bb-9a3d-f8dc20de6277Product name120190408

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
62032-111-602019-11-13C16284748780-197449f38-d4a5-f6ea-e053-dbdaa90aa703CLENZIDERM DAILY CARE FOAMING CLEANSER

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
62032-111-60CLENZIDERM DAILY CARE FOAMING CLEANSER ACNE TREATMENT118 mL in 1 BOTTLE, PLASTICLIQUID1181

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
62032-111CLENZIDERM DAILY CARE FOAMING CLEANSER ACNE TREATMENT (SALICYLIC ACID) LIQUID [OMP, INC.]1Legacy NDC, 1 package rows20111221_23625de5-003c-446d-a661-b245cffbe4a0.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
SALICYLIC ACIDACTIVE INGREDIENTO414PZ4LPZ1
SALICYLIC ACIDACTIVE MOIETYO414PZ4LPZ1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 12 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
62032-11162032-111-60

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Name, UNII, Kind table
NameUNIIKind
SALICYLIC ACIDO414PZ4LPZACTIB
SODIUM LAURETH SULFATEBPV390UAP0IACT
DIETHYLENE GLYCOL MONOETHYL ETHERA1A1I8X02BIACT
SODIUM LAURYL SULFATE368GB5141JIACT
COCAMIDOPROPYL BETAINE5OCF3O11KXIACT
CETYL HYDROXYETHYLCELLULOSE (350000 MW)T7SWE4S2TTIACT
EDETATE DISODIUM7FLD91C86KIACT
MENTHOLL7T10EIP3AIACT
MENTHYL LACTATE2BF9E65L7IIACT
EXT. D&C VIOLET NO. 2G5UX3K0728IACT
WATER059QF0KO0RIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
209d04e7-f03e-4697-9a04-f0d7026bdba023625de5-003c-446d-a661-b245cffbe4a02011-12-15WarningsExact identifier
spl id: 209d04e7-f03e-4697-9a04-f0d7026bdba0
spl set id: 23625de5-003c-446d-a661-b245cffbe4a0

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.